Product Images Tadalafil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Tadalafil NDC 67184-0524 by Qilu Pharmaceutical Co., Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Package Label - 10mg bottle label

Package Label - 10mg bottle label

Package Label - 10mg cart

Package Label - 10mg cart

This text provides information about Tadalfil tablets, USP, with 10 mg strength. The tablets should not be split and the entire dose should be taken. The package contains 90*46*15mm size tablets with NDC number 67184-0525-2. The text includes some illegible characters and symbols and does not provide any additional information about the medication.*

Package Label - 20mg bottle label

Package Label - 20mg bottle label

This appears to be a description of a medication named "Tadaldfil Tablets, USP." It comes in a pack of 30 tablets and is only available with a prescription. The NDC number is listed as 67184-0526-1. There are some symbols and characters that are not readable, so the description may be incomplete or inaccurate.*

Package Label - 20mg cart

Package Label - 20mg cart

This is a description of a drug called Tadalaofil Tablets, USP. The tablets come in a specific size of 90*46*15mm and have a National Drug Code of 67184-0526-2. Each tablet comprises of 20mg Alafil. The tablets should not be split and the entire dosage should be taken. The remaining text is not readable.*

Package Label - 2point5mg bottle label

Package Label - 2point5mg bottle label

This is the description of a medication. The medication comes in the form of 30 tablets, each containing 25mg of the active ingredient. It is intended for once daily use and should not be split. The manufacturer is Qilu Pharmaceutical (Hainan) Co. Ltd, located in Haikou, China. Further information about the medication can be found using the NDC number provided: NDC 67184-0523-1. The given text does not provide any information on the name or purpose of the medication.*

Package Label - 2point5mg carton label

Package Label - 2point5mg carton label

This appears to be a label/box of Tadalafil tablets. The dimensions of the box are 90%67*20mm, and it contains 30 tablets, divided into two cards, each with 15 tablets. Each tablet contains Tadalafil. There are two types of tablets: Tadalafil Tablets, USP for once-daily use and 25mg Tadalafil Tablets, USP, which are prescription-only medicines. The rest of the text is not readable due to errors.*

Package Label - 5mg bottle label

Package Label - 5mg bottle label

Tadalafil Tablets, USP are available in 30 tablet bottle with NDC 67184-0524-1. These tablets should not be shared and entire dose should be taken. The manufacturer of these tablets is Qi Pharmaceutical located in Haikou, 57031. This is a prescription-only medication (Rx only).*

Package Label - 5mg cart

Package Label - 5mg cart

Description: This is a label for Tadalafil tablets that come in a pack of 30 tablets. Each tablet contains 5 mg of Tadalafil, which is used for once-daily use. The measurement of the tablets is 90 x 67 x 20mm.*

Figure - f001

Figure - f001

Figure - f002

Figure - f002

Figure - f003

Figure - f003

Figure - f004

Figure - f004

This is a graph that demonstrates the plasma concentration of Tadalafil in micrograms per liter over time when administered in different doses. The graph shows the concentration for a single 20mg dose of Tadalafil (represented by a solid line), a single 5mg dose of Tadalafil (represented by a dotted line), and once-daily 5mg Tadalafil following five consecutive days of administration (represented by a dashed line). The x-axis represents the time in hours, while the y-axis represents the plasma concentration in micrograms per liter.*

Figure 5 - f005

Figure 5 - f005

The text describes a graph or chart showing the change in IPSS total score over the weeks of treatment. The treatment options are Tadalafil Tablets 5 mg and Placebo. The graph shows that there is no change at the start of treatment (week 0), but a significant improvement is observed in the Tadalafil group after 3 weeks of treatment compared to the Placebo group. The improvement continues to increase over a period of 12 weeks.*

Figure 6 - f006

Figure 6 - f006

The text describes the results of a study comparing the IPSS Total Score between a group of patients taking Tadalafil Tablets 5mg and those taking a placebo. The text provides a graph depicting the results with a statistically significant difference between the two groups (p<0.01). The duration of treatment in weeks is also indicated.*

Figure 7 - f007

Figure 7 - f007

Figure 8 - f008

Figure 8 - f008

This is a report on IPSS Total Score, a measure used in evaluating the severity of lower urinary tract symptoms in men. The report shows the scores for patients who were treated with Tadalafil Tablets 5 mg or placebo for an unspecified duration of weeks. A significant difference was observed between the two treatment groups (p<0.01). The text contains some illegible characters.*

Chemical Structure - structure

Chemical Structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.